Network Immunology Inc. is a leading edge, Vancouver based immunotherapeutics company. The company is developing an entirely novel immunotherapeutic platform called AbstimX™. In pre-clinical studies, AbstimX™ has been shown to be effective in the therapeutic treatment of multiple inflammatory autoimmune and allergic diseases. Network Immunology creates substantial and lasting value through the development of novel immunotherapeutics for licensing and commercialization of those products and their associated intellectual property. The mission of Network Immunology is to enhance and prolong the quality of human and animal lives through the discovery, development and licensing of patented immunotherapeutics.